2-in-1 defense against sore throat

Strepsils

Posted at Jan 28 2022 10:09 AM

Sore throat is one of the major symptoms experienced by people infected with upper respiratory tract infections, whatever the cause, virus or not. Strepsils lozenges provide 2-in-1 defense with symptomatic relief to sore throat and to kill viruses and germs in 60 seconds. Photo source: Strepsils
Sore throat is one of the major symptoms experienced by people infected with upper respiratory tract infections, whatever the cause, COVID or not. Strepsils lozenges provide 2-in-1 defense with symptomatic relief to sore throat and to kill viruses and germs in as fast as 60 seconds. Photo source: Strepsils

With the continued spread of the health crisis that has sickened more than two million Filipinos, many fear that their dry coughs and sore throats may be a sign of COVID-19. And it is a cause for concern as these two, according to the World Health Organization, are some of the most common symptoms. 

While there is currently no cure for COVID-19, it is important to address symptoms as they come in order to offer relief during the recovery process. For sore throat, one of the remedies people can try at the first signs of discomfort is taking lozenges.

Lozenges offer considerable advantage over a gargle

Medicinal Lozenges are one of the Department of Health’s (DOH) recommendations1 for managing COVID-19 symptoms at home. And, results of a clinical studysuggested that among sore throat product formats, ''lozenges offer considerable advantages over a gargle.'' The same study showed that the proportion of medicine delivered to the throat and mouth combined is greater with the lozenges compared to gargles.

Lozenges may offer fast, effective, and long relief for throat pain when compared to gargles. Photo source: Strepsils
Lozenges may offer fast, effective, and long relief for throat pain when compared to gargles. Photo source: Strepsils

Unlike gargles which are expelled from the mouth, lozenges are kept in the mouth longer, providing a steady supply of medicine to the throat. This results in greater activity in both the mouth and the throat for up to 20 minutes even after the lozenge is completely dissolved. Thus, the study concluded that lozenges provide fast, effective, and prolonged delivery of active ingredients beneficial for sore throat relief.

2-in-1 defense against symptoms of sore throat

Sore throats are a common symptom experienced by people with the virus. Strepsils, a lozenge brand that has been around for almost 50 years, offers relief to sore throat. It provides a 2-in-1 defense by delivering deep-down relief that can last two hours and kill viruses and germs in 60 seconds3

Get 2-in-1 defense at the first signs of sore throat with Strepsils. Photo source: Strepsils
Get 2-in-1 defense at the first signs of sore throat with Strepsils. Photo source: Strepsils

So, if you are looking for sore throat relief in as fast as 60 seconds, Strepsils offers symptomatic relief to help you feel better. Always follow the health protocols including wearing face masks, observing physical distancing, and frequent hand washing, to help prevent the spread of the virus.

A wide range of products for different sore throat needs

There is a Strepsils product for different sore throat needs. Photo source: Strepsils
There is a Strepsils product for different sore throat needs. Photo source: Strepsils
  • For mild sore and itchy throat – Dichlorobenzyl Alcohol + Amylmetacresol (Strepsils® Cool Sensation), also available in other flavors such as Honey & Lemon, Orange, Sugar-Free, and Extra Strong
  • For moderate pain and irritated throat – Hexylresorcinol (Strepsils® Max) 
  • For severe, inflamed sore throat – Flurbiprofen (Strepsils® MaxPro) 

Strepsils is available in all leading drugstores nationwide and online at Lazada and Shopee. For more information, visit its website

If symptoms persist, consult your doctor.

ASC Reference Number: R161N011822SS

References:
1 Limb M, et al. Int J Clin Pract 2009;63:606-12 
2 Limb M, et al. Int J Clin Pract 2009;63:606-12 
3 Oxford JS, Leuwer M. Int J Clin Pract 2011;65:524– 30.

 

NOTE: BrandNews articles are promotional features from our sponsors and not news articles from our editorial staff.